Short Interest in Sandoz Group AG (OTCMKTS:SDZNY) Rises By 25.4%

Sandoz Group AG (OTCMKTS:SDZNY) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 68,600 shares, a growth of 25.4% from the February 28th total of 54,700 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 94,300 shares, the short-interest ratio is presently 0.7 days.

Sandoz Group Trading Down 2.2 %

Shares of Sandoz Group stock opened at $41.00 on Thursday. Sandoz Group has a fifty-two week low of $27.79 and a fifty-two week high of $49.81. The stock has a 50 day moving average of $45.16 and a 200 day moving average of $43.86.

Analyst Upgrades and Downgrades

Separately, UBS Group lowered shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, February 3rd.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.